The phrase "accumulated safety data" is correct and usable in written English.
It can be used in contexts related to research, health, or safety assessments where data has been gathered over time regarding safety measures or incidents.
Example: "The researchers presented their findings based on the accumulated safety data from the past five years."
Alternatives: "collected safety information" or "gathered safety data".
This study accumulated safety data and demonstrated clinical cases of brain metastases visualized by 64Cu-DOTA-trastuzumab PET imaging.
Industrial countries have not accumulated safety data nor industrial standard, testing methodology and safety standard.
The DSMB will review accumulated safety data from the trial and advise the Principal Investigators and the Steering Committee on items related to patient safety.
Because LGG is the most used dietary probiotic, accumulated safety data for LGG as a stand-alone dietary supplement in infants and adults are available.
DSMB members will be asked to give advice on whether the accumulated safety data − notably SAEs − from the trial, together with results from other relevant trials, justify continuing recruitment of further patients.
Those included the disclosure yesterday that Boston Scientific had quietly told federal regulators this summer that new analysis of the company's accumulating safety data found that patients using its best-selling Taxus stent had a slightly greater but statistically clear risk of developing potentially deadly blood clots compared with older stent designs.
The D2d DSMB will regularly review accumulating safety and efficacy data.
This situation presents an urgent need to accumulate safety and efficacy data to support evidence-based medicine (EBM) for treatment with DPP-4 inhibitors and other OHAs.
Some potential sources of the relevant data are discussed below: CDER has now accumulated extensive liver safety data in the eDISH format from over 100 clinical trials involving over 150,000 patients (Dr. John Senior, personal communication).
A Safety Monitoring Committee (SMC) reviewed the safety data accumulated during the four days following the first immunization and recommended commencing immunizations with the higher dose of AMA-1.
The DDC will also review all safety data accumulated in the trial at each meeting.
